Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recalculation of warrants due to completed rights issue and directed share issue in Endomines AB (publ)

Endomines AB, Stock Exchange Release 28 May 2021, at 15:15 CESTAs a result of the rights issue and directed share issue in Endomines AB (publ) (the "Company"), which was resolved by the Board of Directors on November 30, 2020 and subsequently approved by the Annual General Meeting on January 4, 2021 and which was subscribed for to 76.0 percent, recalculations of the subscription price and the number of shares the warrants entitles to subscription for have been made in accordance with the terms and conditions for the Company's warrants of series 2019/2022 and 2020/2023. The terms and

Relais Group Plc – Managers’ Transactions

Relais Group Plc – Managers’ Transactions Relais Group Plc, Company Release, 28.5.2021 at 16.05 EET ____________________________________________ Person subject to the notification requirement Name: Nygård Katri Position: Member of the Board/Deputy member Issuer: Relais Group Oyj LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20210528125856_2 ____________________________________________ Transaction date: 2021-05-28 Venue not applicable Instrument type: SHARE ISIN: FI4000391487 Nature of the

Relais Group Plc – Managers’ Transactions

Relais Group Plc – Managers’ Transactions Relais Group Plc, Company Release, 28.5.2021 at 16.04 EET ____________________________________________ Person subject to the notification requirement Name: Raatikainen Pekka Position: Chief Financial Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20210528114154_2 ____________________________________________ Transaction date: 2021-05-26 Venue not applicable Instrument type: SHARE ISIN: FI4000391487 Nature of the

Relais Group Plc – Managers’ Transactions

Relais Group Plc – Managers’ Transactions Relais Group Plc, Company Release, 28.5.2021 at 16.03 EET ____________________________________________ Person subject to the notification requirement Name: Raatikainen Pekka Position: Chief Financial Officer Issuer: Relais Group Plc LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20210528114154_2 ____________________________________________ Transaction date: 2021-05-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Relais Group Plc – Managers’ Transactions

Relais Group Plc – Managers’ Transactions Relais Group Plc, Company Release, 28.5.2021 at 16.02 EET ____________________________________________ Person subject to the notification requirement Name: Ekholm Arni Position: Chief Executive Officer Issuer: Relais Group Oyj LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20210528123445_3 ____________________________________________ Transaction date: 2021-05-26 Venue not applicable Instrument type: SHARE ISIN: FI4000391487 Nature of the

Intervacc and the Karolinska Institutet sign a multi-year contract for the development of innovative animal health vaccines

Stockholm May 28, 2021 - Intervacc AB (publ) and the Karolinska Institute, KI, announce today that they have extended the contract for the development of a new generation of animal health vaccines using recombinant proteins. The three-year contract means that the research group at Karolinska Institutet, led by Professor Birgitta Henriques Normark, continues to be part of the already very successful collaboration between KI, the Swedish University of Agriculture (SLU) and Intervacc. This collaboration has led to the development of Strangvac, an innovative new vaccine against strangles, a

Relais Group Plc – Managers’ Transactions

Relais Group Plc – Managers’ Transactions Relais Group Plc, Company Release, 28.5.2021 at 16.00 EET ____________________________________________ Person subject to the notification requirement Name: Ekholm Arni Position: Chief Executive Officer Issuer: Relais Group Oyj LEI: 743700X9S8FVYRI20J88 Notification type: INITIAL NOTIFICATION Reference number: 743700X9S8FVYRI20J88_20210528123445_3 ____________________________________________ Transaction date: 2021-05-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Calliditas Announces Submission of Marketing Authorisation Application for Nefecon to the European Medicines Agency

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the company submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Nefecon, a novel oral formulation targeting down regulation of IgA1 for the treatment of primary IgA Nephropathy (IgAN).The submission is based on positive data from Part A of the NefIgArd pivotal Phase 3 study, a randomized, double-blind, placebo-controlled, international multicenter study designed to evaluate the efficacy and safety of Nefecon compared to placebo in 200 adult

Olvi Plc: Transfer of Treasury Shares Under a Matching Share Plan

Olvi Plc           Stock Exchange Release 28 May 2021 at 3.30 pm Olvi Plc: Transfer of Treasury Shares Under a Matching Share Plan Olvi plc has transferred a total of 4.150 Olvi plc Series A shares held as treasury shares to the company's key employees under a matching share plan 2021-2022. In the plan, the target group is given an opportunity to receive matching shares for their personal investment in Olvi plc series A shares.Information on the matching share plan was provided in stock exchange release on 2 February 2021. The transfer of shares is based on an authorisation

Lehto Group Plc: Resolutions of Lehto Group Plc's Annual General Meeting 2021 and the organizing meeting of the Board of Directors

Lehto Group PlcStock Exchange Release28 May 2021 at 3.30 p.m (EET)The Annual General Meeting of shareholders of Lehto Group Plc took place in Kempele in the headquarters of the company in the address Voimatie 6B on 28 May 2021. The Annual General Meeting approved the financial statements for 2020 and discharged the Members of the Board of Directors, the Chairman of the Board of Directors, and the CEO from liability. The use of profit shown on the balance sheet and the payment of dividend The Annual General Meeting resolved in accordance with the proposal by the Board of Directors

Kojamo plc has completed the issue of EUR 350 million green bond under its EMTN programme

Kojamo plc Stock Exchange Release 28 May 2021, at 3:25 p.m. EESTKojamo plc has completed the issue of EUR 350 million green bond under its EMTN programme NOT FOR PUBLISHING OR DISTRIBUTION, WHETHER IN WHOLE OR IN PART, EITHER DIRECTLY OR INDIRECTLY IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR IN ANY OTHER COUNTRIES WHERE PUBLICATION OR DISTRIBUTION WOULD BE AGAINST THE LAW Kojamo plc has today completed the issue of its EUR 350 million senior unsecured green notes (the “Notes”) under its EMTN programme. The maturity of the euro-

Collector Bank issues senior unsecured bond of SEK 400m

As part of Collector’s focus on increased diversification of funding, Collector’s subsidiary Collector Bank AB has issued a senior unsecured bond of SEK 400 million.Collector Bank AB, a wholly owned subsidiary of Collector AB, has issued a senior unsecured bond of SEK 400 million in the Nordic market. The bond has a two-year-tenor, with maturity in June 2023, and will be listed on Nasdaq Stockholm.The bond was issued under Collector Bank’s MTN programme, with a total frame of SEK 5 billion, and will carry a variable interest of 3m STIBOR +1.35%.Collector’s primary source of financing is

FDA grants Breakthrough Device Designation for Smart orthopedic implants

Cork, Ireland, Gothenburg, Sweden & Houston, Texas (May 28, 2021) -- Intelligent Implants Ltd (II), a development-stage, medical device company with offices in Cork, Ireland, Gothenburg, Sweden and Houston, Texas has announced today that its SmartFuse® system has received Breakthrough Device Designation by the US Food and Drug Administration (FDA). Intelligent Implants SmartFuse technology is a wirelessly enabled orthopedics platform that has been designed to remotely stimulate, control, and monitor bone growth. The goal of the SmartFuse system is to accelerate bone growth and provide

Maersk selects Wärtsilä hybrid solution to support decarbonisation efforts

Wärtsilä Corporation, Press release, 28 May 2021 at 3.15 pm EESTThe technology group Wärtsilä will supply its Wärtsilä HY Module , a containerised hybrid battery power and energy storage system to Maersk Supply Service, the Denmark based provider of offshore marine services and integrated solutions for the global energy sector. The Wärtsilä system will support Maersk’s goal of reducing the carbon intensity of its fleet by 50 percent before the end of this decade. The order with Wärtsilä was placed in May 2021. The hybrid power conversion will be carried out on

Interim Report 28[th] December 2020 to 28[th] March 2021

FRIDAY, 28[th] MAY, 14:00 CETJANUARY to MARCH 2021 · Net sales amounted to £26.3 million · EBITDA before special items amounted to £5,983k up 10.4% on the same quarter last year · Operating profit amounted to £4,561k · Profit before tax amounted to £5,405k · Cash and cash equivalents at the end of the period were £36,573k  Q2 revenues were 7.2% below the same quarter last year due to the inability to deliver in Scotland during the lockdown and the timing of the Christmas holidays.  EBITDA increased by £562k to £5,983k over the same quarter as the previous year despite

New store to take title of northernmost Tokmanni in Finland – Store network to expand to Kittilä, near Levi and Ylläs

Tokmanni     Press release     28 May 2021 at 2:45 p.m. Tokmanni, Finland’s largest general discount retailer, has signed an agreement on the opening of a new store in Kittilä, at the address Aakenuksentie 30, 99100 Kittilä. The aim is to open the new store in a new, yet unconstructed commercial building before the end of the current year. Once the new store opens, the Tokmanni in Sodankylä will relinquish its title of northernmost Tokmanni store to Kittilä. The new Tokmanni store will be serving its customers in a good location in the immediate vicinity of the junction between

BioStock: Spotlight on MS

World MS Day will be celebrated on Sunday May 30th. It is a day to raise awareness of the condition, and to support and connect people living with the disease worldwide. Although over 2.5 million people are suffering from multiple sclerosis there is currently no treatment that is efficient across all patient groups. To fill this void the Swedish biotech company Cyxone is intensifying its efforts on their drug candidate, T20K, intended for a long-term MS treatment to stop disease progression, avoiding devastating side effects and more convenient to take compared to existing treatments.Read

Notice of Biohit Oyj’s annual general meeting

Biohit Oyj Stock Exchange Release May 28, 2021 at 02:00 pm local time (EEST)   Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, June 23, 2021 starting at 11:00 am at the Company’s headquarter. The address is Laippatie 1, 00880 Helsinki. Participation and exercise of shareholder rights in the Meeting by shareholders or their proxy representatives is possible only by voting in advance and by submitting counterproposals and asking questions in advance in accordance with the instructions given in this notice and otherwise by the

Publication of Biohit Oyj Renumeration Report 2020

Biohit Oyj Renumeration Report May 28, 2021 at 02:00 pm local time (EET)   Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/. Additional information: Chairman of the Board Osmo Suovaniemi, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com 

LKAB develops a new mining method

When mining depths in underground mines increase, so do the challenges. Therefore, an entirely new method has been developed – raise caving. This is a major groundbreaking step towards a safer, more efficient mine."Raise caving has been developed for efficient mining at great depth," says Matthias Wimmer, mining engineering manager at LKAB in Kiruna.Rock stresses increase as mining moves to ever greater depth. A more complex geometry, in combination with rock-mechanical challenges, places demands on new, sustainable and innovative solutions for the mine of the future. And, underground,

Decisions by the Annual General Meeting of Apetit Plc

Apetit Plc, Stock exchange release, 28 May 2021 at 2.00 p.m.Decisions by the Annual General Meeting of Apetit Plc The Annual General Meeting on 28 May 2021 approved the parent company's and consolidated financial statements for the financial year 1 January - 31 December 2020 and discharged the members of the Supervisory Board and the Board of Directors and the CEO from liability. The Board of Directors' proposals were approved without changes. DIVIDEND The Annual General Meeting decided that a dividend of EUR 0.50 per share will be paid for the financial year 2020. The dividend

Susanne Ohlsén Appointed as Managing Director Teknos Sweden

Teknos is pleased to announce the appointment of Susanne Ohlsén as Managing Director for Teknos Sweden starting from 1st of August 2021.Teknos is pleased to announce the appointment of Susanne Ohlsén as Managing Director for Teknos Sweden starting from 1st of August 2021.   Susanne joined Teknos in June 2018 as HR Manager where she streamlined the HR processes and increased the efficiency of our HR routines in Sweden. In her role as HR manager, Susanne is also a member of the Teknos Group HR Council and has also taken on leading responsibilities for strategic projects within the company.

Flowscape receives software order in the UK and Ireland

A British company in the financial services sector has selected Flowscape's solution to book desks and parking spaces for all three of its offices in Great Britain and Ireland. The solution is considered a key element of their digital workplace strategy post-pandemic. The order value in the first year is GBP 40,000 and thereafter GBP 32,000 annually."The UK is now starting to reopen, and we are seeing an increasing number of incoming requests for our products. This customer enquiry was received from our website and following a pilot, they have now chosen to implement Flowscape's solution in

CEO Patrik Dahlen purchases Immunovia shares

LUND, SWEDEN - Immunovia AB (publ) (“Immunovia”) announces today that Patrik Dahlen, CEO of Immunovia, has purchased 6,860 shares for approximately SEK 675,000 over the stock exchange. His total holding now amounts to 51,860 shares in Immunovia. For more information, please contact:Patrik Dahlen, CEO ImmunoviaEmail: patrik.dahlen@immunovia.comTel: +46 73 376 76 64 About ImmunoviaImmunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s proprietary test

There are no items matching the current filter
There are no more items matching the current filter
Back to top